DNA vaccines: a review

Area of Science:

• Immunology and Vaccinology
• Molecular Biology
• Biotechnology

Background:

• DNA vaccines utilize circular DNA (plasmids) encoding specific antigens to induce immune responses in mammalian cells.
• This technology presents a versatile platform for generating cytolytic T lymphocyte (CTL), T helper cell, and antibody immunity.
• DNA vaccine technology offers potential for global application due to ease of manufacturing, broad administration, and safety.

Purpose of the Study:

• To provide a comprehensive overview of DNA vaccine technology.
• To review the mechanisms, preclinical, and clinical efficacy of DNA vaccines.
• To discuss the limitations of first-generation DNA vaccines and highlight promising second-generation advancements.

Main Methods:

• Review of existing literature on DNA vaccine mechanisms.
• Analysis of preclinical and clinical trial data for DNA vaccines.
• Exploration of DNA vaccine applications in proteomics for gene function elucidation.

Main Results:

• DNA vaccines effectively induce various types of immunity, including CTL, T helper cells, and antibodies.
• The technology demonstrates broad applicability, ranging from infectious diseases to cancer and autoimmune disorders.
• Second-generation DNA vaccines show promise in overcoming limitations of earlier versions.

Conclusions:

• DNA vaccines represent a powerful and adaptable platform for diverse therapeutic and prophylactic applications.
• Ongoing developments in DNA vaccine technology are expanding its potential in medicine and research.
• The review underscores the significant potential of DNA vaccines for global health challenges.